Advanced search×
×

European Neuropsychopharmacology

Print ISSN
0924-977X
Electronic ISSN
1873-7862
Impact factor
4.201
Publisher
Sciencedirect
URL
http://www.sciencedirect.com/science/journal/0924977X
Usage rank
2775
Article count
1650
Free count
6
Free percentage
0.00363636
PDFs via platforms
Sciencedirect, Gale, Ingenta, CSA, Rcgp, and Proquest

  1. Prenatal stress affects insulin-like growth factor-1 (IGF-1) level and IGF-1 receptor phosphorylation in the brain of adult rats.

    European Neuropsychopharmacology 24(9):1546 (2014) PMID 25106693

    It has been shown that stressful events occurring in early life have a powerful influence on the development of the central nervous system. Insulin-like growth factor-1 (IGF-1) promotes the growth, differentiation and survival of both neurons and glial cells and is thought to exert antidepressant-li...
  2. Abnormal thermoregulation in drug-free male schizophrenia patients.

    European Neuropsychopharmacology 11(4):285 (2001) PMID 11532382

    We hypothesized that a standardized exercise-heat tolerance test [two 50-min bouts of walking a motor-driven treadmill at 40 degrees C (relative humidity=40%)] would reveal abnormal thermoregulation in drug-free schizophrenia patients. Six drug-free schizophrenia outpatients and seven healthy compar...
  3. Pindolol can be effectively given once or twice daily for augmentation in psychiatric patients.

    European Neuropsychopharmacology 10(6):511 (2000) PMID 11115742

  4. Neuroimaging of serotonin uptake sites and antidepressant binding sites in the thalamus of humans and 'higher' animals.

    European Neuropsychopharmacology 9(6):537 (1999) PMID 10625123

    This review presents the results of in vitro, ex vivo and in vivo studies carried out primarily for identifying serotonin uptake sites and/or antidepressant binding sites in the brain of humans and 'higher' animals, namely nonhuman primates and pigs. Five lines of evidence are considered. First, stu...
  5. Missing action of carbamazepine on postsynaptic GABA-responses of hippocampal CA3-neurons (slice, guinea pig).

    European Neuropsychopharmacology 8(4):353 (1998) PMID 9928928

    Conflicting data exist concerning the interaction of carbamazepine (CBZ) and GABA-receptors involved in the pathophysiology of neuropsychiatric disorders. The present study reveals that CBZ failed to alter membrane potential fluctuations mediated by an activation of postsynaptic GABA(A)- and GABA(B)...
  6. Dizocilpine (MK-801) and tetrodotoxin influence accumbal dopamine release evoked by intrapallidal morphine.

    European Neuropsychopharmacology 8(1):47 (1998) PMID 9452940

    We examined whether changes in accumbal dopamine and its metabolites produced by intrapallidal morphine a) are associated with local excitatory amino acid neurotransmission b) are determined by impulse propagation in dopamine neurons and c) are observed both ipsi- and contralateral to the morphine a...
  7. Tianeptine and alcohol dependence.

    European Neuropsychopharmacology 7 Suppl 3:S347 (1997) PMID 9405962

    Several arguments are in favour of the use of antidepressant drugs in alcohol-dependent patients, especially those acting on the serotoninergic system: (1) neurochemical data indicate the interaction between alcohol and 5-HT metabolism, (2) pharmacological studies show an improvement in the behaviou...
  8. The effects of antidepressants on psychomotor function with particular reference to reboxetine.

    European Neuropsychopharmacology 7 Suppl 1:S17 (1997) PMID 9169307

    This review assesses the relative efficacy and side-effect profile of the currently available treatment options for major depression and the new selective noradrenergic agent, reboxetine. The effects of these treatments on psychomotor function are reviewed using: choice reaction time (CRT) and criti...
  9. Psychomotor retardation is a scar of past depressive episodes, revealed by simple cognitive tests.

    European Neuropsychopharmacology 24(10):1630 (2014) PMID 25129432

    We assessed the role of the Retardation Depressive Scale (filled in by the clinician) and the time required to perform the neurocognitive d2 attention test and the Trail Making Test (performed by patients) in a sample of 2048 depressed outpatients, before and after 6 to 8 weeks of treatment with ago...
  10. Hallucinogen persisting perception disorder and the serotonergic system: a comprehensive review including new MDMA-related clinical cases.

    European Neuropsychopharmacology 24(8):1309 (2014) PMID 24933532

    We present 31 new HPPD cases that link HPPD to the use of ecstasy (MDMA), which is known to reverse serotonin reuptake and acts as agonist on 5-HT₂A receptors. The available evidence suggests that HPPD symptoms may be a result from a misbalance of inhibitory-excitatory activity in low-level visual p...